An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021228
Company: UPJOHN

Products on NDA 021228

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DETROL LA	TOLTERODINE TARTRATE	2MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	AB	Yes	No
DETROL LA	TOLTERODINE TARTRATE	4MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021228

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/22/2000	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21228lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21228ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-228_Detrol.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/13/2018	SUPPL-23	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021228s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021228Orig1s023ltr.pdf
07/28/2014	SUPPL-22	Manufacturing (CMC)		Label is not available on this site.
08/01/2012	SUPPL-21	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021228s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021228Orig1s021ltr.pdf
09/20/2011	SUPPL-16	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021228s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021228s016ltr.pdf
01/05/2010	SUPPL-15	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021228s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021228s015ltr.pdf
09/11/2008	SUPPL-12	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020771s019, 021228s012ltr.pdf
03/16/2007	SUPPL-10	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021228Orig1s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020771s017, 21228s010ltr.pdf
07/14/2005	SUPPL-8	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021228s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021228s008ltr.pdf
10/20/2005	SUPPL-7	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021228s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021228s007ltr.pdf
04/14/2004	SUPPL-6	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21228se8-006_detrol_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21228se8-006ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021228_S006_DetrolTOC.cfm
01/15/2004	SUPPL-5	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21228slr005ltr.pdf
07/21/2003	SUPPL-4	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21228slr004ltr.pdf
12/17/2001	SUPPL-3	Manufacturing (CMC)	Review	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021228_S003_DetrolTOC.cfm
09/21/2001	SUPPL-2	Labeling	Review	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021228_S002_DetrolTOC.cfm
04/27/2001	SUPPL-1	Labeling	Label (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21228s1lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021228_S001_DetrolTOC.cfm

Labels for NDA 021228

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/13/2018	SUPPL-23	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021228s023lbl.pdf
08/01/2012	SUPPL-21	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021228s021lbl.pdf
09/20/2011	SUPPL-16	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021228s016lbl.pdf
01/05/2010	SUPPL-15	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021228s015lbl.pdf
03/16/2007	SUPPL-10	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021228Orig1s010lbl.pdf
10/20/2005	SUPPL-7	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021228s007lbl.pdf
07/14/2005	SUPPL-8	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021228s008lbl.pdf
04/14/2004	SUPPL-6	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21228se8-006_detrol_lbl.pdf
04/27/2001	SUPPL-1	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21228s1lbl.pdf
12/22/2000	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21228lbl.pdf

Therapeutic Equivalents for NDA 021228

DETROL LA

CAPSULE, EXTENDED RELEASE;ORAL; 2MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DETROL LA	TOLTERODINE TARTRATE	2MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	021228	UPJOHN
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	2MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	213397	AJANTA PHARMA LTD
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	2MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	213858	AMTA
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	2MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	206419	HETERO LABS LTD III
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	2MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	204562	INVENTIA HLTHCARE
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	2MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	079141	TEVA PHARMS USA
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	2MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	203016	TORRENT

CAPSULE, EXTENDED RELEASE;ORAL; 4MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DETROL LA	TOLTERODINE TARTRATE	4MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	021228	UPJOHN
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	4MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	213397	AJANTA PHARMA LTD
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	4MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	213858	AMTA
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	4MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	206419	HETERO LABS LTD III
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	4MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	204562	INVENTIA HLTHCARE
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	4MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	079141	TEVA PHARMS USA
TOLTERODINE TARTRATE	TOLTERODINE TARTRATE	4MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	203016	TORRENT

Top